FIELD: medicine.
SUBSTANCE: invention relates to field of cell biotechnology, veterinary and medicine. Method of treating experimental tuberculosis in mice includes introduction of suspension of bone marrow cells into affected mice. Bone marrow cells are isolated from femoral bone of inbred mice line AKR, resistant to tuberculosis. Introduction is performed into caudal vein once a week in dose 6 mln cells per a mouse during two months. Method allows to reduce number of mycobacteria in organism of experimental animals considerably and guarantees elongation of affected animals life.
EFFECT: invention can be used in veterinary and medicine.
2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD TO TREAT EXPERIMENTAL TUBERCULOSIS IN MICE OF LINE C57BL/6(H-2) | 2012 |
|
RU2496868C1 |
| COMBINED ANTITUBERCULOUS COMPOSITION | 2009 |
|
RU2413517C1 |
| COMBINED ANTITUBERCULOUS COMPOSITION | 2010 |
|
RU2468802C2 |
| AGENT FOR TREATMENT FOR PROPHYLAXIS OF TUBERCULOSIS | 2004 |
|
RU2262349C1 |
| COFORMULATED ANTITUBERCULOUS DRUG | 2009 |
|
RU2430724C2 |
| METHOD FOR TREATING DIFFERENT FORMS OF PULMONARY TUBERCULOSIS, RESISTANT TO ANTITUBERCULAR CHEMOTHERAPY, AMONG THEM | 2001 |
|
RU2197984C1 |
| METHOD OF TREATING PULMONARY TUBERCULOSIS FEATURING PREDOMINANTLY EXUDATIVE TYPE OF INFLAMMATION | 1990 |
|
RU2008902C1 |
| PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | 2011 |
|
RU2478389C2 |
| METHOD OF TREATING TUBERCULOSIS WITH MULTIPLE DRUG RESISTANCE | 2013 |
|
RU2554753C2 |
| 5-METHYL-7-(3-NITRO-[1,2,4]TRIAZOL-1-YL)-[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE, HAVING ANTI-TUBERCULOSIS ACTIVITY AGAINST THE AGENT WITH MULTIPLE DRUG RESISTANCE, AND A METHOD FOR PRODUCTION THEREOF | 2018 |
|
RU2705591C1 |
